Loss of Efficacy of Famotidine in the Control of Gastric Acid Secretion in Patients with Zollinger-Ellison Syndrome Reversed by Omeprazole

1989 ◽  
Vol 24 (sup166) ◽  
pp. 180-180
Author(s):  
V. Corleto ◽  
B. Annibale ◽  
A. Saggioro ◽  
M. Puoti ◽  
M. Cassetta ◽  
...  
1979 ◽  
Vol 17 (8) ◽  
pp. 29-32

Cimetidine (Tagamet - SKF) is the first histamine-H2 receptor antagonist in general use. It reduces gastric acid secretion and is marketed for the treatment of duodenal ulcer, benign gastric ulcer, recurrent and stomal ulceration, reflux oesophagitis and Zollinger-Ellison syndrome.


BMJ ◽  
1973 ◽  
Vol 2 (5859) ◽  
pp. 139-141 ◽  
Author(s):  
M. R. Lewin ◽  
B. H. Stagg ◽  
C. G. Clark

1972 ◽  
Vol 62 (4) ◽  
pp. 626-631 ◽  
Author(s):  
Jon I. Isenberg ◽  
John H. Walsh ◽  
Edward Passaro ◽  
Edward W. Moore ◽  
Morton I. Grossman

1983 ◽  
Vol 84 (1) ◽  
pp. 108-113 ◽  
Author(s):  
J-P. Raufman ◽  
S.M. Collins ◽  
S.J. Pandol ◽  
L.Y. Korman ◽  
M.J. Collen ◽  
...  

1975 ◽  
Vol 20 (3) ◽  
pp. 280-281 ◽  
Author(s):  
Michael Mainardi ◽  
Vernon Maxwell ◽  
Richard A. L. Sturdevant ◽  
Jon I. Isenberg

Sign in / Sign up

Export Citation Format

Share Document